(1) A prescription drug outlet shall submit information in the manner required by the board.
(2) A practitioner who has, in good faith, written a prescription for a controlled substance to a patient is not liable for information submitted to the program. A practitioner, the designee of a practitioner or medical director, or a prescription drug outlet that has, in good faith, submitted the required information to the program is not liable for participation in the program.
Source: L. 2019: Entire title R&RE with relocations, (HB 19-1172), ch. 136, p. 1500, § 1, effective October 1. L. 2024: (2) amended, (SB 24-047), ch. 440, p. 3073, § 5, effective June 6.